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ABSTRACT
Phase variably expressed (randomly switching)
methyltransferases associated with type III
restriction-modification (R-M) systems have been
identified in a variety of pathogenic bacteria. We
have previously shown that a phase variable methyl-
transferase (Mod) associated with a type III R-M
system in Haemophilus influenzae strain Rd coordi-
nates the random switching of expression of multi-
ple genes, and constitutes a phase variable
regulon—‘phasevarion’. We have now identified the
recognition site for the Mod methyltransferase in
H. influenzae strain Rd as 5’-CGAAT-3’. This is the
same recognition site as the previously described
HinfIII system. A survey of 59H. influenzae strains
indicated significant sequence heterogeneity in the
central, variable region of the mod gene associated
with target site recognition. Intra- and inter-strain
transformation experiments using Mod methylated
or non-methylated plasmids, and a methylation site
assay demonstrated that the sequence heterogene-
ity seen in the region encoding target site specificity
does correlate to distinct target sites. Mutations
were identified within the res gene in several strains
surveyed indicating that Res is not functional.
These data suggest that evolution of this type III
R-M system into an epigenetic mechanism for
controlling gene expression has, in some strains,
resulted in loss of the DNA restriction function.
INTRODUCTION
Restriction-modiﬁcation (R-M) systems are ubiquitous in
bacteria and are involved in protection of the bacterial cell
from incoming foreign DNA. R-M systems are comprised
of two enzymes: a methyltransferase and a restriction
endonuclease. The methyltransferase catalyses the methyl-
ation of a speciﬁc DNA recognition sequence distinguish-
ing ‘self’ DNA and protecting it from cleavage (1,2).
The restriction endonuclease catalyses the double-
stranded cleavage of unmethylated ‘non-self’ DNA. R-M
systems are classiﬁed into three major groups: types I, II
and III (3). In type II systems, the most common type of
R-M system (3), the methyltransferase activity and
restriction activity are performed by two independently
acting enzymes (4). In the more complex type I systems,
methyltransferase activity and restriction activity are
performed by the same holoenzyme, which consists of
three types of subunits: S, M and R encoded by hsdS,
hsdM and hsdR, respectively. The S and M subunits
are required for methyltransferase activity, and all
three subunits are necessary for restriction activity (5).
Type III systems consist of only two subunits, the
methyltransferase (modiﬁcation, Mod) subunit
which can independently function as a methyltransferase
(6,7) and the restriction (Res) subunit which must
form a complex with Mod to recognize and cleave
DNA (8).
Phase variation is the reversible, high frequency switch-
ing of gene expression. In Haemophilus inﬂuenzae and
several other mucosal pathogens, phase variation is
commonly mediated by mutations in simple tandem
DNA repeats in the open reading frame or promoter
region of phase variable genes (9,10). Phase variation is
usually associated with genes encoding surface expressed
virulence determinants, where switching of expression
allows the generation of a diverse population of pheno-
typically distinct cells—some of which will be better
adapted to survival. There are several examples of
type III R-M systems in a variety of pathogenic bacteria
that have been proven to undergo phase variation
[H. inﬂuenzae (11) and Helicobacter pylori (12)] or from
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variation [Pasteurella haemolytica (13), Neisseria
meningitidis, Neisseria gonorrhoeae (14) and Moraxella
catarrhalis (15)]. Several proposals have been made as to
the functional signiﬁcance of phase variable type III R-M
systems (16) but these have not been tested experimentally.
Classically, R-M systems are thought to provide resistance
to invading bacteriophages or foreign DNA acquired via
natural transformation (17–20). In this context phase
variation may permit temporary removal of this restric-
tion barrier, allowing the acquisition of foreign, poten-
tially beneﬁcial, DNA molecules (19). It has also been
suggested that phase variation of methyltransferases may
lead to autolytic self-DNA degradation by the cognate
restriction enzyme and that such systems may be suicidal
(19,21). This would lead to release of DNA into the
environment for uptake by other cells, potentially to the
beneﬁt of the population (19,21). An alternative function
for phase variable methyltransferases may be gene
regulation, mediated by diﬀerential methylation of the
genome (15). It has previously been established that DNA
methylation can aﬀect gene expression in several systems
(e.g. Dam methylation) (22), however, there were no
examples where the methyltransferase aﬀecting gene
expression is itself phase variably expressed. Recent
work from our laboratory has shown that in H. inﬂuenzae
strain Rd, a phase variable methyltransferase (Mod) of a
type III R-M system coordinates the random switching of
expression of multiple genes, and constitutes a phase
variable regulon—‘phasevarion’ (23). H. inﬂuenzae is an
important human pathogen causing invasive diseases,
such as meningitis and respiratory tract infections.
Functional phasevarions have also recently been con-
ﬁrmed in the human pathogens, N. meningitidis and
N. gonorrhoeae, where a mod gene also coordinates
expression of a regulon of many genes, several of which
have a potential role in pathogenesis (Srikhanta et al.,
submitted for publication). Since a role in gene regulation
is now established in several systems, the question arises of
whether during evolution the role of these type III R-M
systems has become exclusively gene regulation, or
whether their role as DNA restriction systems has
been retained.
MATERIALS AND METHODS
Bacterial isolates
Fifty-nine H. inﬂuenzae isolates were used in this study, as
described in Table 1 of Supplementary Data. Strains
included a set of 24 Finnish otitis media isolates that
have been used in several previous studies (24–27).
The other NTHi isolates have also been described
previously (28). Encapsulated strains included type strains
from the American Type Culture Collection (ATCC) as
well as clinical isolates from the A. Smith laboratory and
strains from the E. R. Moxon laboratory. For strains
that had not previously been typed, multilocus
sequence typing (MLST) was carried out as previously
described (26). Strain details and sequence types were
submitted to the public H. inﬂuenzae MLST website
(haemophilus.mlst.net). An UPGMA (unweighted pair
group method using arithmetic mean) dendrogram
was constructed using the START2 collection of MLST-
related software available at http://pubmlst.org/software/
analysis/start2/(29).
Bacterial growth conditions
Haemophilus inﬂuenzae was grown at 378C in brain heart
infusion (BHI) broth supplemented with hemin (10mg/ml)
and NAD (2mg/ml). BHI plates were prepared with 1%
(v/v) agar and supplemented with 10% (v/v) Levinthal
base (30) and when appropriate kanamycin (10mg/ml)
or tetracycline (5mg/ml).
DNA preparation, manipulation and analysis
All enzymes were sourced from New England Biolabs.
PCR was performed using primers purchased from Sigma
Proligo (Table 2 of Supplementary Data). Primers him6A
and him11 were used to amplify the variable region of the
mod gene, primers him1 and him3 or him4 and him5 were
used to amplify the mod repeat tract, and primers
HI1059for and HI1052rev were used to amplify across
the mod/res region. The region of the res gene containing
known frameshift mutations was ampliﬁed using
primers HI1054for and HI1054rev or HI1054for2 and
HI1054rev2. Sequencing reactions were prepared using
PCR products as template and Big-Dye sequencing
kit (Perkin Elmer). Samples were analysed using
a 3130xl Capillary Electrophoresis Genetic Analyser
(Applied Biosystems International). Data were analysed
using MacVector (version 9.0) and DNA Sequencher.
To analyse DNA fragment sizes, PCR products, ampliﬁed
using a primer set in which the forward primer was
labelled with 6-carboxyﬂuorescein (6-FAM), were ana-
lysed using the GeneScan system (Applied Biosystems
International). Southern hybridization analysis was
carried out as described by Sambrook et al. (31) using a
DIG-labelled (Roche) PCR product as a probe.
To conﬁrm the presence/absence of the mod gene, primers
him7 and him2 (Table 2, Supplementary Data) were
used to PCR amplify the 30 conserved region of mod from
strain Rd DNA and this PCR product was used as
a probe.
Construction ofmodand res mutantstrains of H.influenzae
Sheared genomic DNA from the Rdmod::kan mutant
strain previously described (23) was used to transform
non-typeable H. inﬂuenzae isolates R2866 and 162 by the
MIV method (32). Mod::kan transformants were selected
on BHI plates containing kanamycin and conﬁrmed
by PCR and Southern analysis. The res gene was PCR
ampliﬁed using primers ResF and ResR. The PCR
product was cloned into pGEM-Teasy vector (Promega),
digested with HindIII and blunted using Klenow poly-
merase (New England Biolabs). The Tn903 kanamycin
resistance cassette from the pUC4K vector (Pharmacia)
was excised using HincII and inserted into the blunt
HindIII site. The resulting plasmid, pGEMres::kan, was
linearized by digestion with NcoI and used to transform
non-typeable H. inﬂuenzae isolates 162 by the MIV
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plates containing kanamycin and conﬁrmed by
PCR analysis.
Transformationof H.influenzae
Bacteria harvested from ﬁve plates of conﬂuent growth on
BHI agar supplemented with Levinthal base were resus-
pended in 20ml of ice-cold sterile water containing 15%
v/v glycerol and 272mM sucrose (pH 7.4). Bacteria were
centrifuged for 2min at 13 000 r.p.m. and resuspended in
1ml sterile water (containing sucrose and glycerol).
This step was repeated 4–5 times, keeping the cells on
ice between spins. The OD of the cell suspension was
measured and normalized to an OD 600 of 10. One
microgram of DNA was added to the cells that were then
incubated on ice for 2min. Cells were electroporated
(Bio-Rad micropulser electroporator, 2.5kV, 0.2cm
cuvettes) and BHI broth was added immediately. After
90min incubation at 378C with shaking, cells were plated
on BHI agar containing tetracycline. After overnight
growth, single colonies were selected, grown in broth and
plasmid prepared using the Qiagen Plasmid Midi Kit
(Qiagen, Doncaster, Vic, Au). For the quantitative
transformation experiments, numbers of transformants
were recorded. Twelve colonies were picked for sequen-
cing of the mod repeat tract and a sample of the cell
population was subject to fragment size analysis using
the GeneScan system, as previously described (33).
The transformation eﬃciency was calculated as
number of colonies/mg DNA. The ratio of mod ON to
mod OFF cells in the mod ON recipient cell population
was checked pre- and post-transformation by fragment
size analysis and conﬁrmed to be unchanged.
ApoI cleavageassay
Plasmid pHStet was extracted from H. inﬂuenzae strain
Rd mod ON and mod::kan cells, or R2866 mod ON and
mod::kan cells using the Qiagen Plasmid Midi Kit
(Qiagen, Doncaster, Vic, Au). One microgram of each
plasmid was digested overnight with ApoI according to
manufacturer’s instructions and the resulting fragments
were separated on a 2% high resolution agarose gel
(Nusieve 3:1 Agarose,Cambrex BioScience, Rockland,
ME, USA) with TBE at 70V for 2h and visualized
under UV illumination. Similarly, digests were carried
out using TaqI.
SouthWestern analysis
Plasmid pHStet was extracted from H. inﬂuenzae strain
R2866 mod ON and mod::kan cells using the Qiagen
Plasmid Midi Kit (Qiagen, Doncaster, Vic, Au). Mod
ON cells were veriﬁed by sequencing the repeat tract.
Five micrograms of each plasmid was digested overnight
with DpnI according to manufacturer’s instructions and
the resulting fragments were separated on a 1.5% high
resolution agarose gel (Nusieve 3:1 Agarose,Cambrex
BioScience, Rockland, ME, USA) with TBE at 70V for
2h. The separated DNA fragments were transferred
to nitrocellulose membrane (GeneScreen, Perkin Elmer,
Rowville, Vic, Au) using overnight capillary transfer with
10  SSC. The DNA was cross-linked to the membrane by
exposure to UV light, and then the membrane was washed
three times in TBST (100mM Tris-HCl pH 8.0, 200mM
NaCl, 1mM EDTA, 0.5% Tween 20) for 5min with gentle
agitation. The membrane was blocked for 1h in 3%
BSA in TBST with gentle agitation after which it was
incubated for 1h in 10ml of a 1:1000 dilution of a rabbit
anti-N6-methyl-adenine monoclonal antibody (Megabase
Research Products, Lincoln, NE, USA) in the above
blocking solution. The membrane was washed three times
for 5min in TBST prior to being incubated in a 1:20 000
dilution of a goat anti-rabbit IgG alkaline phosphatase
conjugate antibody (Sigma-Adrich, Castle Hill, NSW, Au)
in blocking solution for another hour. After another three
washes, the membrane was immersed in 10ml of Sigma
FAST BCIP/NBT (Sigma-Aldrich) substrate.
RESULTS
H. influenzae strain Rd mod recognition site is
5’-CGAAT-3’
Early work on H. inﬂuenzae strain Rf DNA restriction
systems characterized the recognition sequence for a type
III R-M system (HinfIII) as 50-CGAAT-30 (34). The
H. inﬂuenzae strain Rd genome sequence contains a single
R-M system with homology to type III systems, encoded
by the mod and res genes (35). The mod gene is subject to
phase variable expression due to a 50-AGTC-30 tetranu-
cleotide repeat tract within the open reading frame (11,23).
To investigate whether the recognition sequence for Mod
in strain Rd is the same as that for HinfIII, plasmid
pHStet (36) was grown in strain Rd mod ON (40 repeats)
and strain Rdmod::kan cells. The resulting methylated
or non-methylated plasmids were then digested with
an enzyme whose recognition sequence overlaps the
proposed methylation sequence. Digestion by ApoI
(50-RAATTY-30) is known to be inhibited by methylation
of either of the adenines of the HinfIII sequence
(Figure 1a). Only one of the multiple ApoI sites in
pHStet overlaps with a HinfIII site and would potentially
be inhibited by methylation. A 1.3-kb ApoI fragment
containing this overlapping HinfIII/ApoI site was
observed after digestion of the strain Rd mod
ON derived (methylated) plasmid with ApoI. This band
was absent from the strain Rdmod::kan-derived
(non-methylated) plasmid digest (Figure 1b), indicating
inhibition of ApoI digestion by methylation of the
DNA by Mod. We conclude that Mod from strain Rd
has the same site speciﬁcity as HinfIII (50-CGAAT-30).
Here, we also demonstrate that it is the second adenine in
the HinfIII sequence that is methylated. This is demon-
strated by digestion of pHStet with TaqI. The TaqI
recognition site (50-TCGA-30) overlaps with the ﬁrst
adenine of the HinfIII sequence. The TaqI cleavage
pattern of pHStet, isolated from Rd mod ON and
mod::kan cells, is identical, indicating that this base is
not methylated by Mod (Figure 1c). This conﬁrms the
ﬁndings of a previous study, in which DNA methylated by
the HinfIII enzyme, isolated from H. inﬂuenzae strain
5244 Nucleic Acids Research, 2007, Vol. 35, No. 15Rf, using S-[methyl-
3H] adenosyl methionine, was cleaved
by TaqI (34).
Evidence that the Modrecognition site is distinctin
other strains of H.influenzae
An alignment of four mod gene sequences, from the four
strains of H. inﬂuenzae for which the genomes have
been sequenced and made available, indicated division of
the mod gene sequence into three domains, typical of mod
genes of type III R-M systems (37). The N- and
C-terminal regions of the protein show between 90 and
96% similarity in sequence amongst the genome-
sequenced strains, and are separated by a central
domain that is completely dissimilar between strains,
showing only 29–31% amino acid sequence similarity.
This is consistent with previous ﬁndings that Mod proteins
are highly conserved in the N- and C-terminal thirds of the
protein with relatively low conservation in the central
third (17,37). This central portion of the protein has been
proposed to play a role in target sequence recognition and
binding, and in binding of the methyl donor (38).
The conserved regions are proposed to play a role in
protein–protein interactions between Mod and Res.
To test whether the variant mod alleles present amongst
genome sequenced strains of H. inﬂuenzae encode proteins
with the same or distinct DNA recognition sequences, the
ApoI restriction inhibition assay described above was
carried out on plasmids derived from non-typeable
H. inﬂuenzae (NTHi) strain R2866 (strain R2866). This
strain was chosen since it contains a mod repeat tract
length permissive for expression of the gene and it has a
Rd mod ON
Rd mod::kan
R2866 mod ON
R2866 mod::kan
1018 bp
500 bp
1636 bp
1018 bp
500 bp
298 bp
ApoI
TaqI
TCGAATTT
HinfIII
Apo I
m
ApoI ApoI
1.3 kb
ApoI/HinfIII
TaqI
500 bp
1018 bp
Rd mod ON
Rd mod::kan
1636 bp
(b)
(c)( d)
(a)
R2866 mod ON
R2866 mod::kan
R2866 mod ON
R2866 mod::kan
Figure 1. Assessment of Mod methylation in H. inﬂuenzae strains Rd and R2866. (a) Schematic diagram showing the overlapping recognition sites
for restriction endonucleases HinfIII, ApoI and TaqI. Plasmid pHStet contains one overlapping ApoI/HinfIII, located on a 1.3-kb fragment.
(b) ApoI digest of plasmid pHStet isolated from Rd mod ON and mod::kan cells, or R2866 mod ON and mod::kan cells. Diﬀerential cleavage pattern
of the 1.3-kb fragment evident with plasmid isolated from Rd mod ON and mod::kan cells. (c) TaqI digest of plasmid pHStet isolated from Rd mod
ON and mod::kan cells. The recognition site for restriction endonuclease TaqI overlaps with the ﬁrst A of the HinfIII recognition sequence
[see schematic in part (a)]. No diﬀerence in the cleavage pattern evident between plasmid isolated from Rd mod ON and mod::kan cells. (d) DpnI
digest of plasmid pHStet isolated from R2866 mod ON and R2866 mod::kan cells (ﬁrst panel). Separated DNA fragments were transferred to
nitrocellulose membrane and probed with anti-N6-methyladenosine antisera (second panel). Diﬀerential binding of the antisera to plasmid isolated
from R2866 mod ON and R2866 mod::kan cells is indicated by an arrow. Increased background in the R2866 mod ON sample compared to
the R2866 mod::kan sample is due to diﬀerential binding of the antisera to chromosomal DNA.
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strain background, the ApoI restriction pattern of plasmid
pHStet was identical for plasmid derived from strain
R2866 mod ON cells and mod::kan cells (Figure 1b),
indicating that the methylation site speciﬁed by strain
R2866 Mod, and hence the restriction site, is distinct from
that of strain Rd Mod (i.e. not HinfIII; 50-CGAAT-30).
However to conﬁrm this, it was necessary to demonstrate
that Mod is actually active in this strain. Plasmid pHStet
isolated from R2866 mod ON and mod::kan cells was
digested; separated DNA fragments were transferred
to nitrocellulose membrane and probed with anti-N6-
methyladenosine antisera. The antisera bound to all of the
separated DNA fragments, indicating that endogenous
methylases were methylating many sites within the
plasmid. With one of the DNA fragments, diﬀerential
binding of the antisera to plasmid isolated from R2866
mod ON and mod::kan cells was observed, indicating that
many Mod methylation sites occur within this fragment
allowing for an observable diﬀerence in antisera binding
between the isogenic strains. This diﬀerence in antisera
binding between wild-type and mod mutant conﬁrms that
Mod is an active methyltransferase in this strain
(Figure 1d).
Heterogeneity inmod genesequence defines 15 groups
inH. influenzae strains
The sequence heterogeneity observed amongst the mod
genes of the genome sequenced strains of H. inﬂuenzae
(see above) and our experimental data supporting the
correlation between mod sequence type and recognition
site speciﬁcity, highlighted the need for a phylogenetic
analysis of the mod gene from a genetically diverse set of
H. inﬂuenzae strains. Encapsulated strains of H. inﬂuenzae
are associated with invasive diseases such as meningitis
and pneumonia, while acapsular or non-typeable
H. inﬂuenzae (NTHi) strains are associated with otitis
media and respiratory tract infections (39). We examined
the mod gene in 59 strains, including 43 NTHi and
16 encapsulated strains. The genetic relatedness of these
strains had been determined by multilocus sequence
typing (MLST). PCR ampliﬁcation and DNA sequencing
of the central variable region of the mod gene and the
mod repeat tract indicated signiﬁcant heterogeneity.
We identiﬁed 15 mod sequence groups in the
H. inﬂuenzae survey, such that within a group the variable
region sequence showed >95% amino acid similarity.
Between groups, the percentage sequence similarity of the
variable region of the protein ranged from 29 to 38%.
During the course of this study, Bayliss et al. (40) reported
mod sequences of 22 NTHi isolates, constituting a subset
of the NTHi collection described above, and proposed
mod groupings. To avoid confusion, we have assigned the
same numbers for common mod groups. The relationship
of the 15 H. inﬂuenzae sequence groups to a MLST
dendrogram is shown in Figure 2. A correlation is evident
between mod sequence type and capsular serotype.
Each strain from a particular capsular serotype shares
an identical mod sequence type to all other members of
that serotype, with the exception of one type f strain,
ATCC 9833. All capsular type d strains possess a unique
mod sequence type (Group 1). Capsular type e and
f strains that contain the mod gene (two type e strains
lacked mod and res), share a common mod sequence type
that is unique from all other capsular or non-typeable
strains (Group 14). Capsular type b strains share a mod
sequence type with a number of NTHi isolates (Group 2).
The serotype a strain examined does not possess a mod
gene and the mod sequence from the one serotype c strain
is unlike all other sequences identiﬁed (Group 16).
The NTHi isolates show signiﬁcant diversity in their
mod gene sequence, with the NTHi isolates being
distributed across 12 mod sequence groups. This ﬁnding
is generally consistent with previous reports of the overall
genetic diversity of NTHi strains, relative to encapsulated
strains (26,27).
In three capsular H. inﬂuenzae strains (ATCC 9006,
type a; ATCC 8142, type e; R3368, type e) no mod and res
gene could be identiﬁed. PCR ampliﬁcation with primers
that bind to the genes ﬂanking mod and res gave a product
size consistent with the absence of mod and res. DNA
sequencing of this PCR product indicated that only the
ﬂanking genes and a small amount of intergenic sequence
was present (Figure 3). No remnant of the mod or res gene
was found, indicating that either a clean deletion event
had occurred or that these strains had never acquired
this R-M system. Southern analysis using a probe
against the 30 conserved region of mod indicated that
these genes were not present elsewhere within the genome
(data not shown).
A correlation is evident between mod repeat tract
sequence and capsular serotype. The repeat unit
50-AGTC-30 was found in all strains of capsular
serotype d, while the repeat unit 50-AGCC-30 was found
in all other strains containing repeats, including NTHi
isolates and strains of capsular serotypes b, c and f.
A correlation is also evident between mod sequence group
and the length of the mod repeat tract. In three of
the 15 sequence groups, there is no repeat tract within the
mod gene. Two of these groups are made up of NTHi
isolates only (Groups 6 and 7), the other group contains
capsular type e and f strains (Group 14). In these strains
the DNA sequence 50-TCAGATAGTCAG-30 is present
in place of the repeat tract. The mod gene is not predicted
to be phase variable in these strains. Of the other twelve
mod sequence groups, some groups contain predominantly
low numbers of repeats or no repeats (Groups 3, 4, 5 and
8) and some contain predominantly high numbers of
repeats (Groups 1, 2, 9 and 10). It has previously been
reported in strain Rd that the length of the repeat tract
correlates to the rate of mod phase variation (11). The
phase variability of mod expression and the rate at which
this occurs may reﬂect functional diﬀerences amongst
diﬀerent mod alleles. No correlation was detected in this
study between mod sequence group or mod repeat tract
length and disease phenotype of the corresponding strains
(Figure 2).
Noted also are pathogenic Neisseria genes that deﬁne
mod groups 11, 12 and 13. Previous work by Kroll et al.
(41) reported the mod res genes of the type III R-M system
as clear examples of horizontally transferred genes
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Figure 2. Phylogenetic relatedness of 59H. inﬂuenzae strains, based on MLST data, and the relationship to mod sequence group, mod repeat tract
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to the strain name indicate that the res gene in that strain has a frame shift mutation and is inactive.
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In mod group 13 we show an example of NTHi isolate
R3023, which has the same DNA recognition domain
sequence as N. gonorrhoeae strain FA1090. The four
NTHi isolates in mod group 7 have the same DNA
recognition domain sequence as the Neisseria lactamica
genome strain (Sanger Institute, UK). These genes clearly
have a common origin. Due to the high sequence
conservation of mod in H. inﬂuenzae and Neisseria species,
the common DNA repeats mediating phase variation and
the common origin via horizontal gene transfer, we
propose the following nomenclature. The genes referred
to in Figure 2 are hence called modA, followed by a
number corresponding to the mod grouping based on
the DNA recognition site allele, recognizing the key
phenotype of DNA recognition speciﬁcity (e.g. the
nt-R3023 gene is modA13). This avoids confusion in
nomenclature with organisms like pathogenic Neisseria,
which contain multiple mod genes that are distinct over the
whole length of their sequence.
Inactivating mutations within theres geneoccur in
multiple strains
Unlike the signiﬁcant diversity observed in the mod
sequence amongst strains of H. inﬂuenzae, the res sequence
is more highly conserved amongst the genome sequence
strains of NTHi and strain Rd. The protein encoded
by the res ORF varies in length amongst these strains
from 722 amino acids (aa) in strain 86-028NP to 930 aa in
strain Rd. The 930 aa Res protein from strain Rd and the
929 aa Res protein from strains R2866 and R2846 are
similar in size to the homologous Res protein from other
organisms. Alignment of the nucleotide sequence of the
res genes from these four strains indicates homology to
the full-length gene sequence in all cases although in strain
86-028NP, a single base pair deletion results in a frame-
shift mutation truncating 207 aa from the C-terminus of
the protein. The Res subunit of type III R-M systems
contains several sequence motifs characteristic of DNA
and RNA superfamily II helicases (42). These conserved
motifs include the ATP-binding motif (TGxGKT) (42,43)
(AGTC)32OFF
(AGCC)3OFF
(AGCC)3OFF
DNA recognition
domain
mod res pcaC rnhB
Repeats
(AGCC)16ON
R539
(AGCC)39OFF
TGxGKT DEAH
Endonuclease 
      domain
R2866
Eagan
162
500 bp
R2846
86-028NP
Rd
Figure 3. Schematic diagram of the region of the genome containing the mod and res genes of six H. inﬂuenzae strains. Block arrows represent genes.
The white regions of the block arrow representing the mod gene indicate the conserved N- and C-terminal regions. The coloured boxed region
indicates the variable central region encoding DNA sequence recognition. The black box represents the position of the mod repeat tract indicated by
an arrow, the sequence of the repeated motif, number of repeats and expression state of the gene are indicated below the black box. The block arrow
representing the res gene indicates that the gene sequence is full-length in each case, with the transition from black to grey representing the position
of a frame shift mutation. An asterisk indicates the position of a stop codon brought in frame due to the frame shift mutation in res. Strain Rd has
no frame shift mutation in res. The genome sequence of strain KW20 Rd does have a frame shift mutation in res. It is not known whether this
diﬀerence represents a sequencing error in the genome sequence or a genuine strain diﬀerence. The positions of the conserved motifs that are
important in Res function are indicated above Res. Triangles indicate the site of insertion of a kanamycin resistance cassette. The solid black
line indicates the intergenic region and the dotted line indicates a deletion.
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weakly conserved sequence ‘PD...(D/E)XK’ is found at
the C-terminus of the Res protein which represents the
endonuclease domain or active site, a signature found in
several types of nucleases (44). This region of the protein is
involved in metal binding, a requirement for DNA
cleavage by several restriction enzymes (45). The trunca-
tion at the C-terminus of the strain 86-028NP protein
results in loss of the endonuclease domain, and the protein
is predicted to be inactive (Figure 3).
To investigate whether the same 86-028NP single base
pair frame shift mutation is found in the res gene of other
strains, a 1.3-kb region of the res gene encompassing the
86-028NP mutation was sequenced in the 56 strains
containing mod and res. The single base pair deletion in
the res gene of 86-028NP was also found in strains nt-723
and nt-1247 (mod group 2). Unexpectedly, a diﬀerent,
32-bp deletion was found in the res gene of four strains in
the mod group 2. This mutation introduced a frame-shift
resulting in a peptide of only 495 aa,—a more extensive
carboxy terminal truncation than the 86-028NP mutation
(see Figure 3). All serogroup b strains tested contain this
mutation, as does the genome sequence serogroup b strain
10810 (Sanger Institute, UK). Conversely, in the res gene
of strains containing a non-phase variable mod gene,
no obvious frame-shift mutations were observed.
Transformation experiments using plasmids specifically
methylated ornon-methylated by Mod totest type III
restriction activity
To further investigate restriction activity of the type III
R-M systems, we used plasmids speciﬁcally methylated or
non-methylated by Mod (i.e. isolated from mod ON
or mod::kan cells, respectively) to transform H. inﬂuenzae
strains Rd and 162. Prior to transformation, the methyla-
tion state of plasmid isolated from strain Rd was checked
using the ApoI inhibition assay described above and by
sequencing of the mod repeat tract, this was not necessary
for strain 162 since mod is constitutively expressed in this
strain. A statistically signiﬁcant diﬀerence in transforma-
tion eﬃciency was shown between Mod methylated
plasmids and non-methylated plasmids transformed into
the homologous strain (mod ON cells of strain Rd or 162)
(Table 1). The Mod methylated plasmids transformed
only two times more eﬃciently into these strains than non-
methylated plasmids. This diﬀerence in transformation
eﬃciency is attributable entirely to the activity of the type
III R-M system and is independent of other R-M systems,
which remain unchanged in the isogenic wild-type/
mod::kan strain pairs.
When Mod methylated plasmids were transformed
into the heterologous strain (i.e. plasmid isolated from
Rd mod ON cells transformed into 162, and vice versa), a
signiﬁcant diﬀerence in transformation eﬃciency was
observed between plasmids methylated in the same
strain and plasmids methylated in a heterologous strain
(Table 1). This signiﬁcant reduction in transformation
eﬃciency is due to diﬀerences in other, non-type III
methylation systems between these two strains.
The contribution of the Mod-Res system to the overall
restriction barrier is indicated by the transformation
eﬃciency of non-methylated plasmids. Although the
transformation eﬃciency is signiﬁcantly decreased com-
pared to Mod-methylated plasmids, 43% of plasmids are
still able to transform the cells, indicating that these
type III R-M systems play only a minor role in the overall
defence of the cell against invasion by foreign DNA.
DISCUSSION
We have previously shown that H. inﬂuenzae strain Rd
Mod is a phase variably expressed, epigenetic regulator of
multiple genes—a phasevarion (23). Here we report that
the recognition sequence for Mod is 50-CGAAT-30, the
same as previously reported for HinfIII (46). This is a key
ﬁnding enabling our studies resolving how ON/OFF
switching of methylation inﬂuences the promoters of
genes controlled by the phasevarion of strain Rd.
Identiﬁcation of the strain Rd Mod target site also
enabled design of strategies used in this study to address
functional and evolutionary questions presented by phase
variable type III R-M systems of H. inﬂuenzae.
Comparisons of the mod and res genes from the genome
strains, and our large scale survey of capsulate and NT
H. inﬂuenzae revealed a wide range of variation in the
region of the mod gene thought to dictate sequence
speciﬁcity (37,40). This variation was also observed in the
recent NTHi sequence analysis conducted by Bayliss et al.
(40). Here we used an ApoI inhibition assay to demon-
strate that the modA10 gene of strain R2866 (mod group
10) does not modify the same sequence as modA1 of strain
Rd (mod group 1), conﬁrming these enzymes methylate
distinct target sequences. These data provide experimental
evidence that sequence variation observed in the putative
Table 1. Assay of type III-speciﬁc restriction
Recipient cells % Transformation eﬃciency ( SD)
Plasmid source
Rd mod ON Rd mod::kan 162wt (mod ON) 162 mod::kan
Rd mod ON 78 ( 14)
  43 ( 9)
  1.6 (  1.2) ND
162wt (mod ON) 0.1 ( 0.2) ND 83 (  16)
   43 ( 6)
  
Transformation eﬃciency of plasmid DNA isolated from mod ON and mod::kan cells, from H. inﬂuenzae strain Rd or 162, transformed into
H. inﬂuenzae strain Rd or 162 recipient cells. A statistically signiﬁcant diﬀerence (P<0.05) was shown between the transformation eﬃciency using
plasmid isolated from mod ON and mod::kan cells for both strains using the two-tailed Student’s t-test;
 P=0.028;
  P=0.013; SD, standard
deviation. ND not determined.
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in Figure 2, reﬂect Mod proteins with distinct target
sequences. Consistent with these ﬁndings, our recent
work in pathogenic Neisseria has conﬁrmed that phase
variation of the ModA11, 12 and 13 methyltransferases
(see Figure 2) control expression of distinct genes
(Srikhanta, submitted for publication).
These ﬁndings raise the question of whether the 15 mod
groupings in H. inﬂuenzae represent 15 diﬀerent type III
R-M systems or 15 diﬀerent methyltransferases control-
ling phasevarions, and whether these functions are
mutually exclusive. Sequence analysis revealed three
groupings (Groups 6, 7 and 14) in which none of the
mod genes contain tetranucleotide repeat sequences.
These genes are therefore not phase variably expressed,
and by deﬁnition these are not phasevarions. These groups
include strain 162, in which we have demonstrated a
functional type III R-M system. We propose all these
groups, and any other strain with a non-phase variable
modA, are likely to be functional, dedicated type III R-M
systems. In contrast, representatives of modA2 group all
have high numbers of tetranucleotide repeats, consistent
with phase variable expression. Analysis of the res gene
from strains within these groups revealed frame-shift
mutations in res in many cases that are inconsistent with
expression of a functional Res protein. We propose that
these strains, and any other strains with tetranucleotide
repeats in mod, and obvious inactivating mutations in res,
function exclusively as phasevarions. Hence, of the
41 strains in the survey that contain a phase variable
mod gene, seven have an obvious mutation in res and
appear to be dedicated phasevarions. This represents 17%
of strains containing a phase variable mod gene.
The remaining 15 strains that do not contain a phase
variable mod gene are likely to be dedicated, functional,
type III R-M systems. There were no strains in this group
that had a corresponding inactivating mutation in the
res gene. In the strains above the distinct functions
of regulation and restriction appear to be mutually
exclusive.
In a related study, another type of inactivating frame-
shift mutation has been identiﬁed in the res genes
associated with modA11 allele of N. meningitidis
(Figure 2) that results in premature truncation of the
encoded protein and loss of the endonuclease domain, this
mutation is present in 70% of strains with the modA11
allele (Srikhanta et al., submitted for publication). In
N. gonorrhoeae, a 250-aa in-frame deletion has been
observed in Res associated with the modA13 allele, poten-
tially inactivating restriction function (Srikhanta et al.,
submitted for publication). These ﬁndings illustrate that
inactivation of restriction function is common amongst
the modA containing phase variable type III R-M systems.
Transformation experiments with strain Rd and strain
162 measuring the eﬀectiveness of type III-speciﬁc
restriction revealed only a two-fold increase in protection
when the system was active. This appears to be a marginal
level of functionality and raises the question of the
selective advantage of restriction function at this level.
More detailed analysis of restriction function is required
to determine how many of the remaining strains contain a
functional type III restriction system. Sequencing a region
corresponding to one-third of the res gene to look for
86-028NP point mutations, we found a diﬀerent 32-bp
deletion mutation that inactivated res. The possibility
remains that the obvious, inactivating frame-shift muta-
tions found in res genes associated predominantly with
modA2 group, the largest mod group (representing 25% of
strains surveyed), may represent the ‘tip of the iceberg’
with many other possible silencing mechanisms either
unsurveyed or currently undetectable by simple sequence
analysis of these poorly deﬁned enzymes.
The observation of non-functional type III R-M
systems in the modA2 strains containing phase variable
mod genes suggests two possibilities, ﬁrst, that the
restriction function is redundant and has been lost, and
second, that phase variable expression of mod may be
inconsistent with a viable organism if an active Mod-Res
holoenzyme can form. In non-phase variable type III R-M
systems, sites are modiﬁed during replication, and any
unmodiﬁed sites in newly replicated DNA are either in the
same orientation or paired with methylated sites, thereby
preventing suicidal restriction of cellular DNA (8). In a
strain containing an active type III R-M system with a
phase variable mod gene, if the mod gene switches OFF for
several rounds of replication, then phase varies back to
ON, the condition may be lethal or detrimental, as none
of the Mod sites in the genome would be methylated and
protected from cleavage. Our original work in strain Rd
(23), and recent work in pathogenic Neisseria (Srikhanta
et al., submitted for publication), have established a role
for phase variable mod genes in control of gene expression.
This study has revealed that the H. inﬂuenzae strains
associated with human disease may contain a series of
distinct phasevarions. Knowledge of the changes in gene
expression that occur as these phasevarions switch the
organisms between two distinct cell types will have a
major impact on our ability to develop an understanding
of the general principles of host pathogen interactions for
H. inﬂuenzae, and to assess H. inﬂuenzae antigens
as vaccine candidates. Our current understanding is that
the role of the mod-res locus in H. inﬂuenzae biology is in
transition. In some strains of the H. inﬂuenzae population
it retains its function as a type III R-M system, while
in others it plays a key role as a dedicated, randomly
switching, epigenetic mechanism for controlling gene
expression.
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